Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata may involve stress-related changes affecting hormone receptors, leading to reduced cortisol production.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Retinoids can help reduce keratin buildup in skin conditions.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Reflectance confocal microscopy helped diagnose and manage a woman's hair loss without needing a biopsy.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

pCLCA2 protein may help maintain skin structure and function.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

DMBT1 and galectin-3 may help suppress epithelial skin cancer.

Sciellin is a protein that helps form protective layers in skin, hair, and nails.

Retinoic acid affects hair growth and can cause hair loss.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Atypical symptoms in lupus can indicate different kidney issues.

Different keratins have unique expression patterns in mouse skin cells.

Alitretinoin may help treat alopecia areata.

CXCL7 is essential for muscle repair by aiding early neutrophil infiltration.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

EBV infection increases a specific keratin variant in carcinoma cells, possibly affecting cell structure and cancer progression.

CMG2 and TEM8 receptors have distinct roles in skin and growth disorders, affecting collagen breakdown and growth.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Ptprq has multiple forms that change during inner ear development.

A new pair of mouse keratins, 65 kD and 48 kD, are found in specific skin areas and are linked to a unique skin differentiation type.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Retinoic acid changes skin cells to mucosal cells with goblet cells, needing TG2/Gh, Gbx1, and TGF-beta.